MDSpire Home

Filters

Search specialties

Cardiology
Dental
Dermatology
Endocrinology
Family Medicine
Gastroenterology
Hematology
Internal Medicine
Neurology
ObGyn
Oncology
Ophthalmology
Optometry
Pediatrics
Rheumatology
Pulmonary
Psychiatry
Pathology
Surgery
Orthopedic Medicine
Radiology
Otolaryngology
Infectious Disease
Science

Search content formats

Summary
Takeaways
Report
Audio
Quiz
Poll
Top Institutions
Top Thought Leaders
Topic Commentary
Clinical Scorecard

Active filters

Conexiant

July 6, 2026

FDA Issues CRL for Orviglance NDA

Kathryn Wighton
July 6, 2026
2 min

Summary
Takeaways
Insight Report
Poll

Objective: To inform about the FDA's Complete Response Letter regarding Ascelia Pharma's New Drug Application for Orviglance. Approach: FDA Response: The FDA is

...more

The FDA issued a Complete Response Letter for Ascelia Pharma’s New Drug Application for Orviglance.
The FDA requested additional clinical data and product documentation before approving the application.
Ascelia plans to request a Type A meeting with the FDA to understand the issues in detail.
Orviglance is intended for patients with severe kidney impairment needing contrast-enhanced liver MRI.
The New Drug Application was based on nine clinical studies, with the phase 3 SPARKLE study meeting its primary endpoint.

...more

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

Conexiant

July 6, 2026

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Andrea Surnit
July 6, 2026
3 min

Summary
Takeaways
Insight Report
Poll
Clinical Scorecard

Objective: To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic biomarkers of the oral TYK2/JAK1 inhibitor SDC-1801 in healthy participan

...more

SDC-1801 was well tolerated in a phase 1 trial with 95 healthy participants, showing no mortality or serious adverse events.
The study observed pharmacologic activity, with reductions in IP-10 and high-sensitivity C-reactive protein in multiple-dose cohorts.
Pharmacokinetic analyses indicated peak plasma concentrations occurred 3 to 5 hours post-administration, with a half-life of 15 to 27 hours.
Food intake modestly increased drug exposure, suggesting improved absorption through enhanced solubilization.
The study's limitations include its focus on healthy participants and formulation-related differences affecting dose proportionality.

...more

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

View Scorecard

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

Conexiant

July 6, 2026

Why Is Vaginal Estrogen Still Underused?

Andrea Surnit
July 6, 2026
6 min

Summary
Insight Report
Quiz

Objective: To analyze the association between vaginal estrogen prescribing and rates of sepsis, hospital admission, and all-cause mortality in female patients w

...more

2 min

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

The Ophthalmologist

July 6, 2026

Clobetasol Suspension Eases Cataract Inflammation

July 6, 2026
3 min

Summary
Takeaways
Insight Report
Poll

Objective: To evaluate the efficacy and safety of clobetasol propionate ophthalmic suspension 0.05% for controlling inflammation and pain after cataract surgery

...more

Clobetasol propionate ophthalmic suspension 0.05% may effectively control inflammation and pain after cataract surgery.
In Phase 3 trials, clobetasol showed rapid reductions in postoperative inflammation and ocular pain compared to placebo.
Patients treated with clobetasol achieved better visual acuity recovery by day eight post-surgery than those receiving placebo.
The treatment demonstrated a safety profile comparable to placebo, with no significant intraocular pressure increases.
Clobetasol's nanoparticle formulation improves ocular penetration and ease of use, particularly for elderly patients.

...more

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

The Ophthalmologist

July 6, 2026

Atropine's Trade-Off

July 6, 2026
3 min

Takeaways
Insight Report
Poll
Clinical Scorecard

A systematic review evaluated the effects of atropine concentrations from 0.01% to 1% on accommodative amplitude and binocular vision in children.
Atropine's effects on accommodation and binocular vision are dose dependent, with 0.01% showing minimal impact on visual function.
Higher concentrations, particularly 0.05% and above, lead to significant reductions in accommodative amplitude and changes in binocular vision.
The findings suggest a need for clinicians to balance myopia control efficacy with potential visual function trade-offs.
The study emphasizes the importance of individualized treatment plans that consider both myopia management and long-term visual comfort.

...more

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

View Scorecard

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

The Pathologist

July 6, 2026

Can AI Outpace Infectious Diseases?

Jessica Allerton
July 6, 2026
5 min

Summary
Insight Report
Poll

Objective: To explore the risks and opportunities of AI applications in infectious disease diagnostics as discussed by experts in the field. Approach: Expert In

...more

2 min

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

The Pathologist

July 6, 2026

RNA Test Advances Alzheimer's Detection

July 6, 2026
3 min

Summary
Insight Report
Quiz

Objective: To identify a new class of blood nanoparticles that may improve early diagnosis of Alzheimer’s disease. Approach: Study Design: The study analyzed bl

...more

1 min

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

The Analytical Scientist

July 6, 2026

The Scourge of Self-Serving Citation Requests

Victoria F. Samanidou
July 6, 2026
4 min

Summary
Insight Report
Poll

Objective: To discuss the ethical concerns surrounding citation requests made by reviewers during the manuscript review process, particularly those that may ser

...more

2 min

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

The Medicine Maker

July 6, 2026

The Grand Winner

July 6, 2026
7 min

Summary
Quiz
Clinical Scorecard

Objective: To announce the Grand Winner of The Innovation Awards 2025: DOMINA from IMA Active, and highlight its features and impact. Approach: Overview of DOMI

...more

2 min

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

View Scorecard

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

The Medicine Maker

July 6, 2026

AI Framework Helps Identify New CAR T Target

July 6, 2026
3 min

Summary
Insight Report
Quiz

Objective: To develop an AI-assisted framework for identifying new targets for CAR T-cell therapy, specifically focusing on GPNMB as a potential multi-cancer ta

...more

2 min

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

Frontiers In Surgery

July 6, 2026

A cost-effective 3D-printed cement spacer reconstruction in a rare case of calcaneal Ewing sarcoma: a case report and surgical technique

Abdulrahman Alaseem
Fahad Alshayhan
Mansor Aldaijy
Ziyad Alsuwailem
Rayan Alfayez
Waleed Albishi
Hisham Alsanawi
Ibrahim Alshaygy
July 6, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To present a case of Ewing sarcoma of the calcaneus treated with total calcanectomy and reconstruction using a 3D-printed cement spacer, highlighting

...more

4 min

Ewing sarcoma accounts for 15% of primary bone tumors and is most common in children and young adults aged 5 to 20.
Calcaneal involvement in Ewing sarcoma is rare, representing only 5% of cases, typically presenting with non-mechanical pain.
A 19-year-old female with a calcaneal Ewing sarcoma underwent neoadjuvant chemotherapy followed by limb salvage total calcanectomy.
Reconstruction utilized a 3D-printed cement spacer, demonstrating the feasibility of advanced surgical techniques in rare cases.
At 2.5 years post-surgery, the patient developed a deep surgical site infection, which was managed successfully without recurrence.

...more

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

View Scorecard

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

Frontiers In Surgery

July 6, 2026

Explainable machine learning for perioperative surgical site infection risk enrichment after operative treatment of closed pilon fractures: a multicenter retrospective study with external validation

Zhigang Deng
Feifei Zhao
Yanci Zhang
Tao Zhang
Xuebin Zhang
Yang Luo
July 6, 2026

Summary
Insight Report
Poll

Objective: To develop and externally validate explainable machine-learning models for perioperative surgical site infection (SSI) risk enrichment after operativ

...more

3 min

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

Frontiers In Oncology

July 6, 2026

Head and neck squamous cell carcinoma with femoral metastasis: a case report and systematic review of current literature

Hannah Chahal
Joseph Latham
Finlay Ajayi
Sasan Dehbozorgi
Andrew Miller
Gordon Gillespie
July 6, 2026

Summary
Takeaways
Insight Report
Quiz
Clinical Scorecard

Objective: To report a rare case of femoral metastasis arising from HNSCC and to systematically review the existing literature on previously reported cases. App

...more

3 min

Femoral metastasis from head and neck squamous cell carcinoma (HNSCC) is exceptionally rare, with most cases involving the tongue as the primary site.
A systematic review identified six cases of femoral metastasis from HNSCC, with a mean patient age of 57 years and a male predominance of 66.7%.
Time to femoral metastasis varied from six months to 19 years, often associated with advanced disease and early recurrence.
Management of femoral metastasis was primarily palliative, including radiotherapy and orthopaedic interventions for fractures.
Overall prognosis for patients with femoral metastasis from HNSCC is poor, reflecting aggressive tumor biology and limited treatment options.

...more

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

View Scorecard

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

Frontiers In Oncology

July 6, 2026

Histopathological biomarkers of immunotherapy outcome in advanced colorectal cancer: a multicentre retrospective study

Jianying Chen
Yanzhi Chen
Zhigang Chen
July 6, 2026

Summary
Takeaways
Insight Report
Quiz
Clinical Scorecard

Objective: To investigate the prognostic value and treatment-outcome associations of standardized stromal tumor-infiltrating lymphocytes (sTILs), tumor-stroma r

...more

3 min

The study analyzed 210 patients with advanced colorectal cancer treated with PD-1/PD-L1 inhibitors from January 2021 to June 2025.
High standardized stromal tumor-infiltrating lymphocytes (sTILs) were linked to a significantly higher objective response rate compared to low sTILs.
Patients with low tumor-stroma ratio (TSR) exhibited longer median progression-free survival than those with high TSR.
In the proficient mismatch repair subgroup, high sTILs combined with low TSR identified an immune-active phenotype with improved response rates.
The study highlights the potential of routine histopathological features as cost-effective biomarkers for stratifying immunotherapy outcomes in advanced colorectal cancer.

...more

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

View Scorecard

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

Frontiers In Oncology

July 6, 2026

Metastatic malignant melanoma presenting as bilateral acute mastitis in a lactating woman: a case report and literature review

Zilin Wang
Shaowu Zeng
Qiaorong Zhou
Jujiang Guo
July 6, 2026

Summary
Takeaways
Insight Report
Quiz
Clinical Scorecard

Objective: To report a case of bilateral acute mastitis in a postpartum woman that was ultimately diagnosed as metastatic malignant melanoma, highlighting diagn

...more

Bilateral acute mastitis can be a rare presentation of metastatic malignant melanoma, complicating diagnosis in postpartum women.
The case involved a 36-year-old woman misdiagnosed with severe lactational mastitis, later found to have diffusely metastatic melanoma.
Metastatic melanoma to the breast is uncommon, accounting for only 1.3% to 2.7% of reported metastatic cases.
The patient's aggressive disease course included failure to respond to targeted therapy, immunotherapy, and chemotherapy.
This case highlights the need for thorough history-taking and suspicion of metastatic disease in atypical breast presentations.

...more

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

View Scorecard

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

Frontiers In Surgery

July 6, 2026

AI-driven perioperative risk stratification and complication management in craniomaxillofacial surgery: current progress and future directions

HaiLian Chen
Shuang Zou
Linlin Zheng
July 6, 2026

Summary
Takeaways
Insight Report
Quiz
Clinical Scorecard

Objective: To summarize recent advances in AI applications for perioperative risk stratification and complication management in craniomaxillofacial surgery. App

...more

3 min

Craniomaxillofacial surgery involves complex anatomy and high surgical risks, necessitating improved perioperative management strategies.
Artificial intelligence offers potential advancements in perioperative risk assessment and complication management in craniomaxillofacial surgery.
AI applications in this field include preoperative risk assessment, intraoperative decision support, and postoperative outcome quantification.
Current challenges in AI implementation include data quality, model interpretability, and the need for clinical integration.
Future directions for AI in perioperative care focus on multimodal, explainable, and generative AI for personalized management systems.

...more

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

View Scorecard

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

Frontiers In Cardiovascular Medicine

July 6, 2026

Congenital heart defects genetic architecture in a small cohort: an integrated approach to prioritizing variants

Anna V. Korobeinikova
Ekaterina S. Petriaikina
Dmitry I. Tychinin
Vladimir S. Yudin
Naida I. Bulaeva
Sayaly M. Gyulmamedova
Georgy A. Khugaev
Tatiana V. Sukhacheva
Ekaterina A. Snigir
Sergey I. Mitrofanov
Antonina M. Rumyantseva
Dmitry V. Svetlichnyy
Sergey M. Yudin
Elena Z. Golukhova
Veronika I. Skvortsova
July 6, 2026

Summary
Takeaways
Insight Report
Quiz

Objective: To investigate the genetic architecture underlying congenital heart defects (CHD) through whole-genome sequencing in a cohort of patients. Approach:

...more

3 min

Congenital heart defects (CHD) are common structural anomalies affecting about 1% of newborns and are significant causes of infant morbidity and mortality.
Whole-genome sequencing of 50 patients with CHD revealed novel genetic variants and associations specific to different CHD subtypes.
The study identified specific genetic associations, including JARID2 with patent ductus arteriosus and CREBBP with atrioventricular septal defects.
Current genomic annotation databases have limited capacity to discriminate genetic risks for CHD, necessitating subtype-specific assessments.
The findings highlight the polygenic nature of CHD and the need for larger cohorts to enhance understanding and clinical application of genetic insights.

...more

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

Frontiers In Cardiovascular Medicine

July 6, 2026

Spontaneous coronary artery dissection as a threshold disorder of coronary wall integrity

Zhongwei Liu
Jun Wang
July 6, 2026

Summary
Insight Report
Quiz
Poll

Objective: To conceptualize SCAD as a disorder of coronary wall integrity and evaluate its molecular basis, clinical recognition, and management complexities. A

...more

3 min

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

About
Privacy Policy